Highnoon Laboratories partners with Bangladesh-based Beximco Pharmaceuticals for strategic collaboration
Both firms sign MoU to distribute and market specialised pharmaceutical products in Pakistan, focusing on key therapeutic areas
Pakistan’s retail pharma sector surpasses Rs1.049 trillion in sales
Data from IQVIA reveals steep price hikes drive growth as medicine consumption shows minimal increase, raising concerns over affordability
Citi Pharma gets FDA nod to start exporting nutraceuticals to the United States
The pharmaceutical ingredients manufacturer enters the consumer-facing market in the US with a product the US regulator classifies as food, and not drugs
Citi Pharma partners with Mersi Farma to establish advanced API plants in Indonesia
Collaboration to bolster pharmaceutical production and expand nutraceutical market
DPCA uncovers tax evasion in import of cancer drug
KARACHI: A case of tax evasion in import of cancer drug named “Tasigna” has been uncovered by Directorate of Post-Clearance Audit (DPCA).
According to a...
Ferozsons dissociates itself from marketing of unlicensed Covid-19 treatment imported from Bangladesh
Ferozsons Laboratories Limited has dissociated itself from the launch of an unlicensed treatment for Covid-19, being imported from Bangladesh.
Clarifying its position, the company stated,...
Ferozsons subsidiary launches human insulin
Company says Ferulin, developed with the highest quality standards, will provide effective and affordable diabetes treatment to patients
Ferozsons launches biologic to treat diabetes
Pharmaceutical company’s biotech subsidiary to launch the new product in one of Pakistan’s biggest therapeutic areas
Govt backs PPMA’s expansion plans, discusses roadmap for $3 billion pharma export target by 2028
PharmEx Pakistan platform set to drive pharmaceutical exports to $3 billion in three years, and $10 billion over the next five years
Haleon Pakistan targets expansion to 19 countries, aims for 10% export sales share
Haleon plans to boost exports and local manufacturing, with focus on Vietnam, Philippines and local sourcing to reduce import reliance
Pfizer looks beyond COVID sales with $43b deal for cancer drugmaker Seagen
WASHNGTON: Pfizer Inc on Monday struck a roughly $43 billion deal for Seagen Inc to bulk up its cancer treatments portfolio, as the drugmaker...
As Panadol prices stabilise, Haleon’s revenue growth slows
The boost from deregulated drug prices is stalling, causing Haleon to look at new product launches in nutraceuticals and export markets for growth
Pharma industry decides to slash prices of 395 essential drugs
'Prices will not increase if rupee remains stabilised, utility prices are maintained and rate of inflation is controlled'
KARACHI: Pakistan Pharmaceutical Manufacturers' Association (PPMA) on...
Pak pharma industry suffers from government’s shackles
A thriving sector in Pakistan’s economy, pharmaceuticals is a $3.2 billion industry, growing at 15% annually, while its exports now at $US200 million are...
In the first quarter after deregulation, pharma sector revenue up by 25%
The increase in revenue is driven mostly by price increases as drug manufacturers can finally raise prices based on business need and rising costs instead of regulatory fiat
